Paper30188786
Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline.
Fakhry C and 11 others. J Clin Oncol, 2018. Cited by 192 papers, by iCite.
Cite this record
ConductScience Library. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. Papers, record 30188786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30188786
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline.
- PubMed
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Papillomavirus Infections | Major topic |
| Squamous Cell Carcinoma of Head and Neck | Major topic |
| Humans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 30650332 | Errata. | https://conductscience.org/library/papers/30650332 |
Source PubMed
Cited by110
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 192 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889415 | Systemic immune activation coexists with compartment-specific regulatory enrichment in matched blood, peritumor, and tumor tissue from advanced oral squamous cell carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889415 | PubMed |
| 42564913 | Treatment Modality and Survival in Human Papillomavirus (HPV)-Stratified Early-Stage Oropharyngeal Cancer: A Population-Based Propensity Score-Matched Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/42564913 | PubMed |
| 42543416 | HPV-specific treatment trends in oropharyngeal squamous cell carcinoma: a population-based analysis with stage-stratified interaction testing. | Eur Arch Otorhinolaryngol | 2026 | https://conductscience.org/library/papers/42543416 | PubMed |
| 42539714 | Inflammation as a master regulator of immunotherapy response in head and neck squamous cell carcinoma: from malignant transformation to ecology-aware precision combinations. | Front Immunol | 2026 | https://conductscience.org/library/papers/42539714 | PubMed |
| 42482202 | The oral microbiota in oral squamous cell carcinoma: unravelling mechanisms and clinical potential. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42482202 | PubMed |
| 42370167 | Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42370167 | PubMed |
| 42306048 | Irofulven and RSL3 synergistically target ferroptosis-related gene PTGR1 to treat head and neck squamous cell carcinoma. | Open Life Sci | 2026 | https://conductscience.org/library/papers/42306048 | PubMed |
| 42239697 | Detection of human papillomavirus infection in oral mucosal diseases: A single-center study. | JADA Found Sci | 2024 | https://conductscience.org/library/papers/42239697 | PubMed |
| 42099743 | The role of human papillomavirus in oral squamous cell and verrucous carcinomas: a systematic review with case series. | Oncol Rev | 2026 | https://conductscience.org/library/papers/42099743 | PubMed |
| 41959982 | Human Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) and p16 Expression in Squamous Cell Carcinoma of the Head and Neck. | Cureus | 2026 | https://conductscience.org/library/papers/41959982 | PubMed |
| 41816946 | Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer. | Head Neck | 2026 | https://conductscience.org/library/papers/41816946 | PubMed |
| 41515563 | Radiomic-Based Machine Learning Classifiers for HPV Status Prediction in Oropharyngeal Cancer: A Systematic Review and Meta-Analysis. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41515563 | PubMed |
| 41514568 | Detection of Human Papillomavirus (HPV) in HPV-Associated Oropharyngeal Squamous Cell Carcinoma: A Review of Diagnostic Approach and Its Importance for the Head and Neck Oncologist. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41514568 | PubMed |
| 41021082 | High-Risk HPV Testing in Head and Neck Carcinoma: Key Updates from the 2025 College of American Pathologists Guideline. | Head Neck Pathol | 2025 | https://conductscience.org/library/papers/41021082 | PubMed |
| 40940899 | Evaluating Clinical Factors Including HPV Clearance on Survival Outcomes in HPV+ Oropharyngeal Carcinoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940899 | PubMed |
| 40814244 | Subsite variation of HPV-related p16-expression in oropharynx cancer: Incidence and prognostic impact in a population-based DAHANCA cohort 1986-2020. | Acta Oncol | 2025 | https://conductscience.org/library/papers/40814244 | PubMed |
| 40655928 | Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma. | Ger Med Sci | 2025 | https://conductscience.org/library/papers/40655928 | PubMed |
| 40490828 | Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population. | Infect Agent Cancer | 2025 | https://conductscience.org/library/papers/40490828 | PubMed |
| 40211812 | Reduced Dose and Selective Neck Irradiation Policy in Treating Oropharynx Cancer: Excellent Oncological Outcomes with Very Low Risk of Locoregional Failure. | Cancer Res Treat | 2026 | https://conductscience.org/library/papers/40211812 | PubMed |
| 39883130 | [Epidemiology and prevention of oropharyngeal cancer : Summary of the new German S3 guideline]. | HNO | 2025 | https://conductscience.org/library/papers/39883130 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30188786
GET https://conductscience.org/api/papers/v1/30188786/cited_by?page=2